Inhibrx Biosciences INBX
NASDAQ INBX
$104.70 +2.99 (+2.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Enterprise Value (2024 - 2026)

Updated

Inhibrx Biosciences (INBX) reported Enterprise Value of $1.26 billion for Q2 2026, compared with $19.97 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Enterprise Value (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Inhibrx Biosciences' Enterprise Value came in at $796.41 million; for FY2025, it came in at $1.03 billion.

  • By year, Enterprise Value came in at $70.33 million in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Enterprise Value in data going back to Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Inhibrx Biosciences 1.50 Bn 1.50 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Bn
Dec 31, 2025 1.03 Bn
Sep 30, 2025 335.20 Mn
Jun 30, 2025 19.97 Mn
Mar 31, 2025 -14.00 Mn
Dec 31, 2024 70.33 Mn
Sep 30, 2024 30.36 Mn
Jun 30, 2024 -21.78 Mn
API Access

Inhibrx Biosciences Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=INBX&period=max&api_key=YOUR_API_KEY